Shanghai Pharmaceuticals Holding Co Ltd (601607) — Financial Flexibility Index
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥2.05 Billion (operating CF CN¥1.56 Billion minus capex CN¥487.63 Million) represents 0% of total liabilities (CN¥147.12 Billion). Check Shanghai Pharmaceuticals Holding Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Pharmaceuticals Holding Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Shanghai Pharmaceuticals Holding Co Ltd cash conversion from operations.
Annual Financial Flexibility Index for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Shanghai Pharmaceuticals Holding Co Ltd. Explore 601607 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥8.48 Billion | CN¥6.15 Billion | CN¥143.36 Billion | ▼ -1.2% |
| 2024 | 0.06x | CN¥8.23 Billion | CN¥5.83 Billion | CN¥137.47 Billion | ▼ -3.9% |
| 2023 | 0.06x | CN¥8.20 Billion | CN¥5.23 Billion | CN¥131.65 Billion | ▲ +0.8% |
| 2022 | 0.06x | CN¥7.43 Billion | CN¥4.74 Billion | CN¥120.13 Billion | ▼ -29.7% |
| 2021 | 0.09x | CN¥9.18 Billion | CN¥5.06 Billion | CN¥104.37 Billion | ▼ -15.7% |
| 2020 | 0.10x | CN¥9.85 Billion | CN¥6.84 Billion | CN¥94.44 Billion | ▲ +4.2% |
| 2019 | 0.10x | CN¥8.78 Billion | CN¥6.02 Billion | CN¥87.64 Billion | ▲ +58.6% |
| 2018 | 0.06x | CN¥5.08 Billion | CN¥3.14 Billion | CN¥80.45 Billion | ▼ -25.9% |
| 2017 | 0.09x | CN¥4.66 Billion | CN¥2.65 Billion | CN¥54.67 Billion | ▼ -3.8% |
| 2016 | 0.09x | CN¥4.07 Billion | CN¥1.95 Billion | CN¥45.91 Billion | ▲ +17.0% |
| 2015 | 0.08x | CN¥3.07 Billion | CN¥1.35 Billion | CN¥40.54 Billion | ▼ -4.2% |
| 2014 | 0.08x | CN¥2.63 Billion | CN¥1.34 Billion | CN¥33.24 Billion | ▲ +14.9% |
| 2013 | 0.07x | CN¥1.88 Billion | CN¥973.45 Million | CN¥27.31 Billion | ▼ -13.6% |
| 2012 | 0.08x | CN¥1.86 Billion | CN¥1.15 Billion | CN¥23.37 Billion | ▼ -21.0% |
| 2011 | 0.10x | CN¥2.19 Billion | CN¥1.77 Billion | CN¥21.69 Billion | ▼ -26.6% |
| 2010 | 0.14x | CN¥2.24 Billion | CN¥1.69 Billion | CN¥16.28 Billion | ▲ +16.9% |
| 2009 | 0.12x | CN¥744.10 Million | CN¥664.13 Million | CN¥6.33 Billion | ▲ +76.9% |
| 2008 | 0.07x | CN¥376.18 Million | CN¥285.68 Million | CN¥5.67 Billion | ▼ -49.6% |
| 2007 | 0.13x | CN¥681.23 Million | CN¥488.94 Million | CN¥5.17 Billion | ▼ -17.3% |
| 2006 | 0.16x | CN¥734.71 Million | CN¥583.11 Million | CN¥4.61 Billion | ▲ +156.8% |
| 2005 | 0.06x | CN¥271.09 Million | CN¥73.00 Million | CN¥4.37 Billion | ▼ -13.6% |
| 2004 | 0.07x | CN¥316.05 Million | CN¥61.66 Million | CN¥4.40 Billion | ▲ +70.0% |
| 2003 | 0.04x | CN¥170.07 Million | CN¥484.27K | CN¥4.03 Billion | ▼ -62.2% |
| 2002 | 0.11x | CN¥380.28 Million | CN¥100.84 Million | CN¥3.40 Billion | ▲ +31.4% |
| 2001 | 0.09x | CN¥210.44 Million | CN¥65.73 Million | CN¥2.47 Billion | ▼ -24.5% |
| 2000 | 0.11x | CN¥287.31 Million | CN¥146.22 Million | CN¥2.55 Billion | ▲ +14.4% |
| 1999 | 0.10x | CN¥217.15 Million | CN¥164.67 Million | CN¥2.21 Billion | ▲ +265.0% |
| 1998 | -0.06x | CN¥-113.25 Million | CN¥-283.14 Million | CN¥1.90 Billion | — |